Presentation is loading. Please wait.

Presentation is loading. Please wait.

Arie Szatkowski, MD FACC Stern Cardiovascular Foundation Baptist Memorial Healthcare Corporation.

Similar presentations


Presentation on theme: "Arie Szatkowski, MD FACC Stern Cardiovascular Foundation Baptist Memorial Healthcare Corporation."— Presentation transcript:

1 Arie Szatkowski, MD FACC Stern Cardiovascular Foundation Baptist Memorial Healthcare Corporation

2 CV disease is #1 cause of death in the U.S. 9% of all ED visits are for Chest Pain, about 5.5 million to 6 million annually (ambulatory visits account for < 1%) Etiology can be difficult to diagnose NSTEMI affects > 625,000 annually (3/4 ACS)

3

4 A Chest Pain Case A 65 year-old man with a past medical history significant for hypertension and dyslipidemia presents to clinic after 2 episodes of chest pain in past couple days. What do you want to know and do?

5 Typical angina (definite) 1)Substernal chest discomfort with a characteristic quality & duration that is 2) provoked by exertion or stress and 3) relieved by NTG or rest Atypical angina (probable) Meets 2 of above characteristics Noncardiac chest pain Meets 1 or none of typical anginal characteristics

6 EXCLUDE Coronary artery disease and other life-threatening conditions

7 Acute Coronary Syndrome/Myocardial infarction Pulmonary embolus Aortic dissection Tension Pneumothorax Esophageal Rupture *All of these could lead to sudden death*

8 “PQRST” Provocative/palliative factors Quality: character, duration, frequency, associated sxs Radiation Severity Timing Risk factors: age, tobacco use, family history, DM/HTN/Lipids, cocaine; other- DVT/PE, Marfans/Pregnancy, ETOH, NSAIDS PMHx: prior CV w/u & Rx, GI history

9 Postprandial? GI or cardiac disease Exertion? Angina or esophageal pain Cold, emotional stress, sexual intercourse can promote ischemic pain Worse with swallowing? Esophageal origin Body position, movement, deep breathing? Musculoskeletal origin Antacids or food? Gastro- esophageal origin Sublingual nitro? Esophageal or cardiac “GI Cocktail” (viscous lidocaine and antacid)? GI or cardiac Cessation of activity/rest? Ischemic origin Sitting up and leaning forward? Pericarditis

10 Region or location: Radiation to neck, throat, lower jaw, teeth, upper extremity, or shoulder Radiation to arms is useful and stronger predictor of acute MI Between scapulae  think aortic dissection Larger areas of discomfort more likely ischemic etiology Severity: not useful predictor for presence of CAD Timing: Abrupt onset with greatest intensity in beginning: PTX, dissection, acute PE Gradual with increasing onset over time: ischemic Crescendo pattern: esophageal disease Lasts for seconds or constant over weeks ≠ ischemic Circadian rhythm (morning>afternoon) correlating with increase sympathetic tome- more likely myocardial ischemia

11 Belching, bad taste in mouth, dysphagia or odynophagia  esophageal disease Vomiting  Transmural MI, GI problems Diaphoresis  MI> esophageal disease Syncope  dissection, PE, critical AS, ruptured AAA Pre-syncope  myocardial ischemia Palpitations in setting of new A. Fib + chest pain  PE Fatigue  can be presenting complaint of MI esp. in elderly

12 General Appearance may suggest seriousness of symptoms. Vital signs marked difference in blood pressure between arms suggests aortic dissection Palpate the chest wall Hyperesthesia may be due to herpes zoster Complete cardiac examination pericardial rub signs of acute AI or AS Ischemia may result in MI murmur, S4 or S3 Determine if breath sounds are symmetric and if wheezes, crackles or evidence of consolidation

13 EKG “ Normal” reduces probability chest pain is due to AMI, but does NOT exclude serious cardiac etiology (i.e. Unstable Angina) ST elevation, ST depression, or new Q waves- important predictor of Acute Coronary Syndrome (AMI or UA) “Nonspecific” ST and T wave changes is common- may or may not indicate heart disease CXR Useful in acute setting to avoid missing dangerous diagnoses (e.g. PTX, Aortic dissection, Pneumo- mediastinum)

14

15

16 Relationship between cardiac troponin levels and risk of death in patients with ACS. Used with permission from Antman EM, Tanasijevic MJ, Thompson B, et al. Braunwald E et al. Circulation. 2000;102: Copyright © American Heart Association, Inc. All rights reserved.

17 Clinical FeatureLikelihood Ratio (95% CI) Pain in chest or left arm2.7 Chest pain radiation Right Shoulder2.9 ( ) Left arm2.3 ( ) Both left and right arm7.1 ( ) Chest pain most important symptom2.0 History of MI Nausea or vomiting1.9 ( ) Diaphoresis2.0 ( ) Third heart sound3.2 ( ) Hypotension (SBP<80)3.1 ( ) Pulmonary rales on exam2.1 ( )

18 Clinical FeatureLikelihood Ratio (95% CI) Pleuritic chest pain0.2 ( ) Chest pain sharp or stabbing0.3 ( ) Positional chest pain0.3 ( ) Chest pain reproduced with palpation Panju, et al. JAMA 1998;280:14:

19

20 Worsening frequency, intensity, duration, timing (e.g. nocturnal pain, rest pain) of prior angina New onset SOB, nausea, sweating, extreme fatigue in patient with known h/o CVD Onset of typical anginal symptoms in pt without h/o CVD New murmur (or worsening of previously noted murmur), hypotension, diaphoresis, rales, pulmonary edema Transient ST deviation (≥ 1mm) or TWI in multiple precordial leads

21

22 Supply-demand Mismatch Plaque Disruption or Rupture Thrombosis Vasoconstriction Cyclical Flow

23 Fever Tachyarrhythmias Malignant Hypertension Thyrotoxicosis Pheochromocytoma Cocaine use Amphetamine use Critical Aortic Stenosis Supravalvular Aortic Stenosis Obstructive Cardiomyopathy Aortovenous shunts High Output States Congestive Heart Failure Anemia Hypoxemia Polycythemia Hypotension

24

25 Terminology change from unstable angina/NSTEMI to NSTEMI ACS Approach to patient remains unchanged Increase focus on discharge instructions and transition Diagnosis: No benefit of CKMB (Class III) MI only if > 20% rise or fall of troponin Point of care troponin not as specific Special population: Women Class III Early Invasive in Low Risk Women

26 “Ischemia Guided Strategy” replaces “Initial Conservative Management” Immediate Invasive < 2 hours if: Refractory angina CHF signs/symptoms New or worsening MR Hemodynamic instability Sustained VT/VF Early (within 24 hours) New ST segment depression GRACE score > 140 Temporal change in Troponin Delayed Invasive Renal insufficiency LVEF < 40% TIMI > 2 GRACE Risk

27 ACE inhibitors: Class I for NSTE ACS with LVEF < 40% Ticagrelor is Class IIa over Clopidogrel for NSTE ACS early initial anti-platelet therapy Ticagrelor or Prasugrel over Clopidogrel prior to PCI DAPT remains 12 months for DES and BMS Pain control post NSTE ACS discharge: careful assessment for need, first acetaminophen or tramadol, then small dose narcotics, then nonselective NSAIDS (naproxen) PPI for those receiving triple oral antithrombotic therapy or if NSAID used. The data that suggest increased harm are weak.

28

29

30

31

32

33 What are some of the scoring methods currently used? ( )

34 PURSUIT: Does not include troponin assays as part of score and the majority of the score is dependent on patient age. TIMI: Simple to use, but has a poor predictive power (i.e. c- statistic 0.65) GRACE: Very complex to use and a large portion of the score is dependent on the patient age. Also patients not divided into different risk groups FRISC: Like TIMI, is simple to use but has a poor predictive power (i.e. c-statistic 0.70)

35

36 HEART ScoreRisk of MACEProposed Policy ,6%Discharge %X-ECG %CAG Proposed Policy Patients can be divided into three distinct groups. A score of 0-3 indicates a risk of 1.6% for reaching a MACE, and therefore supports a policy of early discharge. In case of a HEART score of 4-6 points, with a risk of MACE of 13%, immediate discharge is not an option. These patients should be admitted for clinical observation and subjected to non-invasive investigations such as repeated troponin or advanced ischemia detection. A HEART score ≥ 7 points, with a risk of 50% for a MACE, calls for early aggressive treatments possibly including invasive strategies without preceding non-invasive testing.

37

38 What they did: 2,440 unselected, chest pain patients from 10 hospitals Applied TIMI, GRACE, and HEART Scores Primary endpoint: Occurrence of major adverse cardiac events (MACE) at 6 weeks MACE = AMI, PCI, CABG, and death Results of Validation Study (Different than original study shown above): Low HEART Score (0 -3) = 1.7% MACE Rate Intermediate HEART Score (4 – 6) = 16.6% MACE Rate High HEART Score (7 – 10) = 50.1% MACE Rate C-statistic of HEART Score (0.83) > TIMI (0.75) > GRACE (0.70)

39

40

41

42

43

44

45 Utilization in ED If not ACS then doesn’t need risk stratification. Appropriate risk stratifying test Patient follow up Weekends Cost assessment (pending) Outcomes assessment (pending)

46

47 Focus on the life threatening causes first Know the indicators for immediate invasive therapy Use Risk Tools but Clinical judgment prevails Know the right test for the situation

48 Evaluation of patients presenting with symptoms suggestive of ACS. ACC indicates American College of Cardiology; AHA, American Heart Association. Amsterdam E A et al. Circulation. 2010;122: Copyright © American Heart Association, Inc. All rights reserved.

49

50

51

52 Likelihood ratio expresses the odds that a given level of a diagnostic test result would be expected in a patient with (as opposed to without) the target disorder Sacket, et al. Clinical Epidemiology

53 Acute Coronary Syndromes - Disposition Mortality is twice as high for missed MI Missed MI is the most successfully litigated claim against EP's. EP’s miss 3-5% OF AMI, this accounts for 25% of malpractice costs against EP’s

54

55

56

57

58


Download ppt "Arie Szatkowski, MD FACC Stern Cardiovascular Foundation Baptist Memorial Healthcare Corporation."

Similar presentations


Ads by Google